GOLDMAN SACHS GROUP INC - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 61 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$4,000
-98.8%
12,298
-97.6%
0.00%
Q1 2022$346,000
-70.6%
508,190
-0.1%
0.00%
Q4 2021$1,175,000
+508.8%
508,475
+1105.3%
0.00%
Q3 2021$193,000
-20.9%
42,186
-23.3%
0.00%
Q2 2021$244,000
-3.2%
55,030
+59.0%
0.00%
Q1 2021$252,000
+9.1%
34,607
+14.3%
0.00%
Q4 2020$231,000
-13.2%
30,290
+3.3%
0.00%
Q3 2020$266,000
-20.6%
29,314
-26.0%
0.00%
Q2 2020$335,000
+159.7%
39,637
+52.0%
0.00%
Q1 2020$129,000
-28.7%
26,070
+3.6%
0.00%
Q4 2019$181,000
-29.3%
25,172
+6.2%
0.00%
Q3 2019$256,000
-62.1%
23,692
-63.5%
0.00%
Q4 2018$675,00064,9490.00%
Other shareholders

There were no reported owners of LOGICBIO THERAPEUTICS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of LOGICBIO THERAPEUTICS INC shareholders